#fda

Collection of fda news, found 191 news.

Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate)

Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate)

  • 9th November 2011

-Commercial rights to HYALGAN transitioned from Sanofi back to Fidia, the brand's owner and manufacturerWholly-owned ...

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

  • 6th October 2011

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

  • 26th September 2011

-      March 2011 Data Confirm Strong Treatment Effect of ...

Syneron's elure Advanced Skin Lightening(TM) Products Wins 'BEST OF BEAUTY' in Allure Magazine

Syneron's elure Advanced Skin Lightening(TM) Products Wins 'BEST OF BEAUTY' in Allure Magazine

  • 21st September 2011

-            - elure Advanced Skin Lightening Products captures the ...

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

  • 13th September 2011

-            - First Randomized Controlled Trial to Show That Basal Plus ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

  • 16th August 2011

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials

  • 13th July 2011

-Initial Results are Encouraging, Spurring Hope for a Treatment Option with a Lower Rate of ...

Largest Multi-centre Evaluation of Radioembolisation Using SIR-Spheres

Largest Multi-centre Evaluation of Radioembolisation Using SIR-Spheres

  • 7th July 2011

-           - ENRY Evaluation in 325 Patients Affirms Efficacy and Safety of ...

New Data Shows Lantus(R) Activation of Insulin Receptor Comparable to Human Insulin

New Data Shows Lantus(R) Activation of Insulin Receptor Comparable to Human Insulin

  • 27th June 2011

-        - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...

Lantus(R)/Apidra(R) SoloSTAR(R) Help to Improve Patient Satisfaction

Lantus(R)/Apidra(R) SoloSTAR(R) Help to Improve Patient Satisfaction

  • 27th June 2011

-        Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...

Phadia First Company to Receive FDA Clearance of Recombinant Allergen Component Tests

Phadia First Company to Receive FDA Clearance of Recombinant Allergen Component Tests

  • 21st June 2011

-510(K) Clearance Covers 13 Molecular Allergen Components     Newly-available tests provide deepest ...

Synthes and Lilly Sign Development and Collaboration Agreement

Synthes and Lilly Sign Development and Collaboration Agreement

  • 10th June 2011

-        Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

  • 8th June 2011

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

  • 8th June 2011

-Designation covers inherited respiratory chain diseases of the mitochondria    Edison Pharmaceuticals, ...

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

  • 7th June 2011

-        - NOT INTENDED FOR US MEDIA    - Ingenol Mebutate is an ...